Answer
Rozanolixizumab reaches peak plasma levels approximately 2 days after subcutaneous administration.
Sources for this answer
- Rystiggo 140 mg/ml solution for injectionUCB Pharma Limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 8Document updated
Sources checked